SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
SeaSpine picks up momentum, posts 3Q18 revenue of US $35.8MM, +12.9% vs. 3Q17....
Nov 12, 2018,
SeaSpine Reports 3Q18 Revenue of $35.8MM, +12.9% vs. 3Q17
NuVasive Gains FDA Clearance for COHERE in XLIF
NuVasive received FDA 510(k) clearance for the COHERE® Porous PEEK device in eXtreme Lateral Interbody Fusion....
Nov 09, 2018, Julie Vetalice
Stryker Completes K2M Acquisition
Stryker closed the previously-announced $1.4BB acquisition of K2M....
Nov 09, 2018, Julie Vetalice
Wright Medical Reports 3Q18 Revenue of $194.1MM, +13.8% vs. 3Q17
Wright Medical reports 3Q18 revenue of US $194.1MM, +13.8% vs. 3Q17....
Nov 09, 2018, Mike Evers
Seikagaku Reports FY 2Q18 Revenue of ¥7,030, -12% vs. FY 2Q17
Seikagaku continues slide caused by drug price reductions, posts FY 2Q18 revenue of ¥7,030 (USD $66MM), -12% vs. FY 2Q17....
Nov 08, 2018, Mike Evers
CartiHeal: Positive Study Results for Agili-C Implant
CartiHeal announced a study demonstrating that its Agili-CÂ implant promotes the regenerative capacity of articular cartilage defects in a human cadaveric...
Nov 07, 2018, Julie Vetalice
Spinal Elements Receives Additional FDA 510(k) Clearance for Ti-Bond Coating Technology
Spinal Elements received additional FDA 510(k) clearance for claims related to the macro-, micro- and nano-surface structure of its Ti-Bond®...
Nov 07, 2018, Julie Vetalice
ConMed Reports 3Q18 Orthopaedic Revenue of $102.9MM, +4.4% vs. 3Q17
ConMed reports 3Q18 orthopaedic revenue of US $102.9MM, +4.4% vs. 3Q17....
Nov 07, 2018, Mike Evers
Smith & Nephew Reports 3Q18 Orthopaedic Revenue of $808.7MM, +2.0% vs. 3Q17
Smith & Nephew reports 3Q18 orthopaedic revenue of US $808.7MM, +2.0% vs. 3Q17...
Nov 07, 2018, Mike Evers
Titan Spine Closes Funding Round
Titan Spine closed a round of Series B financing for an undisclosed amount. Proceeds will support product line additions, sales...
Nov 07, 2018, Julie Vetalice
Loading new posts...
No more posts
